We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
-13.01%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$2.79B
AUM Growth
-$283M
Cap. Flow
-$54.4M
Cap. Flow %
-1.95%
Top 10 Hldgs %
67.96%
Holding
104
New
24
Increased
12
Reduced
21
Closed
21

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$20M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.2M
3
GM icon
General Motors
GM
+$9.45M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.46M
5
CCI icon
Crown Castle
CCI
+$7.4M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$21.4M
2
ACOR
Acorda Therapeutics
ACOR
+$12.8M
3
F icon
Ford
F
+$10.1M
4
TEX icon
Terex
TEX
+$9.24M
5
UAL icon
United Airlines
UAL
+$8.76M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.56%
2 Consumer Discretionary 34.56%
3 Healthcare 22.36%
4 Financials 0.62%
5 Real Estate 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WW
1
DELISTED
WW International
WW
$947M 33.95%
28,749,089
– –
LXRX icon
2
Lexicon Pharmaceuticals
LXRX
$890M
$456M 16.36%
36,196,019
– –
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$129M 4.64%
700,000
-800,000
-53% -$142M
MRK icon
4
CALL
Merck
MRK
$357B
$75.1M 2.69%
1,572,000
+1,048,000
+200% +$47.9M
WFC icon
5
CALL
Wells Fargo
WFC
$273B
$56.8M 2.04%
1,250,000
+250,000
+25% +$10.8M
AAPL icon
6
CALL
Apple
AAPL
$4.86T
$56.1M 2.01%
2,800,000
-2,100,000
-43% -$39.7M
GE icon
7
CALL
GE Aerospace
GE
$329B
$56.1M 2.01%
417,324
-375,592
-47% -$47.3M
HIG icon
8
CALL
Hartford Financial Services
HIG
$36.9B
$41.7M 1.49%
1,150,000
+650,000
+130% +$22.4M
QCOM icon
9
CALL
Qualcomm
QCOM
$192B
$40.8M 1.46%
550,000
-150,000
-21% -$10.6M
FURX
10
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$36.6M 1.31%
870,842
-100,209
-10% -$4.12M
BMRN icon
11
CALL
BioMarin Pharmaceuticals
BMRN
$12.7B
$35.2M 1.26%
500,000
+300,000
+150% +$20.4M
AUXL
12
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$31.1M 1.12%
1,500,000
-1,137,200
-43% -$21.4M
COF icon
13
CALL
Capital One
COF
$127B
$30.6M 1.1%
+400,000
New +$28.5M
AIG icon
14
CALL
American International
AIG
$39.4B
$30.6M 1.1%
+600,000
New +$29.9M
LLY icon
15
CALL
Eli Lilly
LLY
$1.01T
$30.6M 1.1%
600,000
– –
YUM icon
16
CALL
Yum! Brands
YUM
$39.9B
$30.2M 1.08%
556,400
– –
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$12.7B
$28.1M 1.01%
400,000
+150,000
+60% +$10.2M
TEVA icon
18
CALL
Teva Pharmaceuticals
TEVA
$45.1B
$28.1M 1.01%
700,000
– –
BAC icon
19
CALL
Bank of America
BAC
$416B
$27.2M 0.98%
1,750,000
– –
INTC icon
20
CALL
Intel
INTC
$514B
$26M 0.93%
+1,000,000
New +$24.2M
PEP icon
21
CALL
PepsiCo
PEP
$186B
$24.9M 0.89%
300,000
– –
AUXL
22
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$24.9M 0.89%
+1,200,000
New +$22.6M
IMGN
23
DELISTED
Immunogen Inc
IMGN
$24.2M 0.87%
1,650,000
– –
GOOG icon
24
CALL
Alphabet (Google) Class C
GOOG
$4.23T
$22.4M 0.8%
+802,999
New +$20.3M
ACOR
25
DELISTED
Acorda Therapeutics
ACOR
$20.4M 0.73%
5,833
-3,293
-36% -$12.8M
1
2 3 4 5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Artal Group's Q4 2013 Portfolio in Review

As of Q4 2013, Artal Group held 104 positions worth $2.79B, down 9.2% from $3.07B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Artal Group's Q4 2013 filing shows 24 new, 12 increased, 21 reduced and 21 closed positions. Its largest new stake was PHARMACYCLICS INC: 165,000 shares worth $17.5M. The largest sale was AUXILIUM PHARAMCEUTICALS INC, an estimated $21.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Artal Group's largest Q4 2013 buy was PHARMACYCLICS INC: 165,000 shares worth $17.5M.
  • Artal Group added most to BioMarin Pharmaceuticals in Q4 2013, an estimated $10.2M increase.
  • Artal Group's biggest Q4 2013 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $21.4M.
  • Artal Group fully exited Ford in Q4 2013, selling an estimated $10.1M.
  • Artal Group's ten largest holdings make up 68% of its $2.79B portfolio in Q4 2013.
  • Artal Group opened 24 new positions and closed 21 in Q4 2013.
  • Artal Group's portfolio value fell 9.2% quarter-over-quarter to $2.79B.

Based on Artal Group's 13F filing for Q4 2013, filed 14 Feb 2014.